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  Subcohort Non - subcohort  
Total 
sample 
  
Country N Person-years Cases (%) Cases N Female, % 
Age at 
enrolment, 
mean (SD) 
rMED score,    
mean (SD) 
France 581 5,838.49 9 (1.5) 271 852 100.0 56.9 (6.5) 9.2 (2.5) 
Italy 1,952 23,521.82 58 (3.0) 1,287 3,239 64.9 51.3 (7.7) 11.1 (2.4) 
Spain 3,513 45,359.78 254 (7.2) 2,240 5,753 56.5 50.4 (7.8) 11.0 (2.5) 
UK-General population 1,064 12,231.67 28 (2.6) 826 1,890 51.0 60.0 (9.2) 8.2 (2.6) 
UK-Health conscious 234 2,700.93 0 (0.0) 128 362 74.0 50.9 (12.1) 11.0 (2.2) 
Netherlands 1,462 17,533.49 40 (2.7) 767 2,229 80.5 53.7 (10.2) 6.4 (2.3) 
Germany 2,024 21,803.36 60 (3.0) 1,490 3,514 50.2 52.4 (8.3) 7.4 (2.3) 
Sweden 2,887 36,962.52 160 (5.5) 2,385 5,272 52.4 54.9 (9.7) 6.2 (2.4) 
Denmark 2,081 23,052.02 140 (6.7) 1,851 3,932 44.3 57.0 (4.4) 6.8 (2.6) 
Total 15,798 189,004.08 749 (4.7) 11,245 27,043 57.3 53.8 (8.7) 8.4 (3.2) 
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Supplementary Table 1. Distribution of cases and characteristics of the InterAct sample by country 
Abbreviations: rMED: relative Mediterranean diet score. SD: Standard deviation
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Supplementary Table 2.  Multiple adjusted hazard ratios of type 2 diabetes associated with two unit 
increment in the relative-Mediterranean Diet score (rMED) and after alternate subtraction of each of its 
components 
Dietary variable HR * 95%CI P-value † 
rMED overall 0.96 0.94 - 0.99 0.002 
rMED minus vegetables 0.95 0.93 - 0.98 <0.001 
rMED minus fruit and nuts 0.96 0.94 - 0.99 0.003 
rMED minus legumes 0.96 0.94 - 0.99 0.002 
rMED minus fish 0.95 0.93 - 0.98 <0.001 
rMED minus cereals 0.95 0.93 - 0.98 <0.001 
rMED minus olive oil 0.97 0.95 - 1.00 0.027 
rMED minus alcohol 0.98 0.95 - 1.01 0.121 
rMED minus meat & meat products 0.98 0.95 - 1.00 0.058 
rMED minus dairy products 0.96 0.93 - 0.99 0.001 
 
* Modified Cox proportional hazard regression models stratified by center, and adjusted for sex, body 
mass index (as a continuous variable), educational level (no formal education, primary school, 
technical/professional school, secondary school and longer education including university degree), 
physical activity (inactive, moderately inactive, moderately active and active), smoking status (never, 
former and three categories of current smoker: 1-10 cigarettes day-1, 11-20 cigarettes day-1 and  >20 
cigarettes day-1), total calorie intake (as a continuous variable) and corresponding subtracted rMED 
components (codified like in the score). Originally estimated logarithms of type 2 diabetes ratios were 
multiplied by 17/19 and then exponentiated to correct for eighteen point scale (except for rMED 
overall). 
† Calculated from the original numbers. 
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Supplementary Table 3. Sensitivity analyses for risk type 2 diabetes associated with a two-point 
increment in the relative-Mediterranean Diet score (rMED) 
 
  
No. Cases / No. Sub-
cohort * 
HR † 95%CI 
Further adjusting by    
WC ‡ 11,158 / 14,089 0.97 0.94 – 0.99 
Hypertension 11,994 / 15,049 0.95 0.93 – 0.98 
Hyperlipidaemia § 9,449 / 12,322 0.95 0.93 – 0.98 
WC, hypertension and hyperlipidaemia ‡ §  9,449 / 12,322 0.96 0.93 – 0.99 
Excluding    
The first two years of follow-up 10,969 / 14,983 0,96 0.94 –0.99 
Participants with chronic diseases at baseline § ║ 3,823 / 9,602 0.95 0.91 – 0.98 
The first two years of follow-up and participants 
with chronic diseases at baseline § ║  3,565 / 9,568 0.94 0.91 – 0.98 
Miss-reporters of energy according to the 
Goldberg classification 7,605 / 10,580 0.96 0.93 – 1.00 
Additive calibration    
Calibrated rMED score 11,994 / 15,049 0.97 0.94 – 0.99 
Abbreviations: WC: waist circumference. 
* No. in the Sub-cohort excluding T2DM cases.  
† Modified Cox proportional hazard regression models stratified by center and adjusted for sex, body 
mass index (as a continuous variable), educational level (no formal education, primary school, 
technical/professional school, secondary school and longer education including university degree), 
physical activity (inactive, moderately inactive, moderately active and active), smoking status (never, 
former and three categories of current smoker: 1-10 cigarettes day-1, 11-20 cigarettes day-1 and  >20 
cigarettes day-1) and total calorie intake (as a continuous variable).  
‡ Excludes Umea where WC was not recorded. 
§ Excludes Malmo and Umea where hyperlipidaemia was not asked. 
║Participants who reported cardiovascular diseases (myocardial infarction, angina or stroke), 
hypertension, hyperlipidemia or were obese (BMI>30 kg.m-2) at baseline. 
SUPPLEMENTARY DATA 
 
Supplementary Figure 1. Country-specific hazard ratios of type 2 diabetes associated with a two-point increment in the relative-
Mediterranean Diet score (rMED). 
Hazard Ratios and 95% CI derived by modified Cox proportional hazard regression models stratified by center and adjusted sex, body mass 
index (as a continuous variable), educational level (no formal education, primary school, technical/professional school, secondary school and 
longer education including university degree), physical activity (inactive, moderately inactive, moderately active and active), smoking status 
(never, former and three categories of current smoker: 1-10 cigarettes day-1, 11-20 cigarettes day-1 and  >20 cigarettes day-1) and total calorie 
intake (as a continuous variable).Weights are from random effects analysis. 
Abbreviations: UK-HC: UK Health conscious group; UK-GP: UK General population.  
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Supplementary Figure 2. Multivariable hazard ratio of type 2 diabetes associated with a two-point 
increment in the relative-Mediterranean Diet Score (rMED) by country, according to the mean age at 
recruitment in the sub-cohort. 
Area of symbol proportional to sample size (% weight). 
Abbreviations: UK-HC: UK Health conscious group; UK-GP: UK General population 
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